ISSUE #6 July 23, 2025
The BIOPLUS INTERPHEX KOREA 2025
Info Session was held on July 17 at COEX.
Participants were provided with a practical guide covering exhibition strategies, on-site operations, and promotional methods.
KoreaBIO is holding a series of nationwide briefing sessions in July to support the commercialization of biomaterials, parts, and equipment.
The second and third sessions were successfully held in Incheon and Andong. The final session is scheduled to take place in Daejeon on July 24.
∎ SNB-101 Earns Government Backing as Promising Therapy for Small Cell Lung Cancer - The Korea Herald
∎ GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam - The Korea Herald
∎ Peptron wins Korea nod for long-acting Takeda challenger in prostate cancer, early puberty - KBR
∎ Alteogen secures U.S. material patent for ‘ALT-B4’ valid through early 2043 - THE BIO
∎ Samsung Bioepis partners with Harrow for US sales of eye disease biosimilars - KBR
∎ Kangstem Biotech’s core technology for knee osteoarthritis treatment, ‘OSCA,’ registered with U.S. patent - THE BIO
∎ Hanmi Pharmaceutical touts ‘Next GLP-1’ Obesity Drug for technology export: targets muscle preservation and function - THE BIO
∎ LG AI Research launches upgraded AI model Exaone Path 2.0 to improve cancer diagnosis, treatment options - Korea JoongAng Daily
∎ Korea's CorestemChemon expands global CRO reach with ATG Lifetech - Biospectrum Asia
∎ Korea approves DeepQure's HyperQure™ for clinical trial in Atrial Fibrillation - Biospectrum Asia
∎ Environment Ministry Plans National Biodiversity Integration Center to Boost Industries - Chosun Biz
∎ Syntekabio Leads AI Datacenter Shift with Eco-Friendly Natural Convection - Pharm Edaily
∎ Korea to invest ₩40.4 bil. in AI-powered antibody biobetters - KBR
∎ Celltrion Posts Record-High Q2 Earnings with 235% Surge in Operating Profit - Pharm Edaily
∎ Researchers develop rapid drug delivery technology using cell exosomes in Korea - Chosun Biz
∎ Korean bio firms advance NK-T cell lymphoma treatments as market potential grows - Chosun Biz
∎ ENCell CEO Chang Jong-wook: “Competing with CGT CDMO expertise… Successful acquisition of AAV and organoid contracts” - THE BIO
∎ Curocell launches ‘CUROLINK’, an integrated CAR-T therapy solution covering prescription to administration - THE BIO
∎ Robotic esophagectomy cuts hospital stay, complications in esophageal cancer surgery - KBR
∎ New colonoscopy AI detects rare minority polyp types - KBR
∎ GenBody’s ‘hMPV rapid diagnostic test’ receives first-ever MFDS medical device approval in Korea - THE BIO
∎ Korean researchers develop AI to diagnose Parkinson's disease with 99% accuracy - KBR
🎬📽️🎞️
Our Weekly Bio Shorts are dropping soon!
📰
Join our press list
Get KoreaBIO updates
& media resources
💬
Share Your thoughts!
How was your letter today?
✉️
Korean Newsletter
Daily biotech news from Korea and around the world
— in Korean
Explore More
KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
+82-31-628-0037
수신거부 Unsubscribe